Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
Zenas BioPharma (Nasdaq: ZBIO), a clinical-stage biopharmaceutical company, has announced its participation in four major healthcare investor conferences in November and December 2024. The company will present at the Guggenheim's Inaugural Healthcare Innovation Conference in Boston, Jefferies London Healthcare Conference, Citi's Global Healthcare Conference in Miami, and Evercore ISI HealthCONx Conference in Coral Gables. Live webcasts and archived replays of presentations at Jefferies, Citi, and Evercore conferences will be available on the company's website under the Investors and Media section.
Zenas BioPharma (Nasdaq: ZBIO), un'azienda biofarmaceutica in fase clinica, ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel settore sanitario a novembre e dicembre 2024. L'azienda presenterà alla Guggenheim's Inaugural Healthcare Innovation Conference a Boston, alla Jefferies London Healthcare Conference, alla Citi's Global Healthcare Conference a Miami, e alla Evercore ISI HealthCONx Conference a Coral Gables. I webcast in diretta e le repliche archiviate delle presentazioni alle conferenze di Jefferies, Citi ed Evercore saranno disponibili sul sito web dell'azienda nella sezione dedicata a Investitori e Media.
Zenas BioPharma (Nasdaq: ZBIO), una compañía biofarmacéutica en etapa clínica, ha anunciado su participación en cuatro importantes conferencias de inversión en salud en noviembre y diciembre de 2024. La empresa presentará en la Guggenheim's Inaugural Healthcare Innovation Conference en Boston, en la Jefferies London Healthcare Conference, en la Citi's Global Healthcare Conference en Miami, y en la Evercore ISI HealthCONx Conference en Coral Gables. Las transmisiones en vivo y las repeticiones archivadas de las presentaciones en las conferencias de Jefferies, Citi y Evercore estarán disponibles en el sitio web de la empresa en la sección de Inversores y Medios.
제나스 바이오파마 (Nasdaq: ZBIO), 임상 단계의 생물 의약품 회사, 2024년 11월과 12월에 열리는 네 개의 주요 의료 투자자 회의에 참여한다고 발표했습니다. 회사는 보스턴에서 열리는 구겐하임의 첫 번째 의료 혁신 회의, 제퍼리 영국 의료 회의, 마이애미의 시티의 글로벌 의료 회의, 코랄 게이블스의 에버코어 ISI HealthCONx 회의에서 발표할 예정입니다. 제퍼리, 시티, 에버코어 회의에서의 발표에 대한 실시간 웹캐스트와 아카이브된 재생은 회사 웹사이트의 투자자 및 미디어 섹션에서 이용할 수 있습니다.
Zenas BioPharma (Nasdaq: ZBIO), une entreprise biopharmaceutique en phase clinique, a annoncé sa participation à quatre grandes conférences d'investisseurs dans le secteur de la santé en novembre et décembre 2024. L'entreprise présentera lors de la Guggenheim's Inaugural Healthcare Innovation Conference à Boston, de la Jefferies London Healthcare Conference, de la Citi's Global Healthcare Conference à Miami, et de la Evercore ISI HealthCONx Conference à Coral Gables. Les webdiffusions en direct et les rediffusions archivées des présentations lors des conférences Jefferies, Citi et Evercore seront disponibles sur le site web de l'entreprise dans la section Investisseurs et Médias.
Zenas BioPharma (Nasdaq: ZBIO), ein biopharmazeutisches Unternehmen in der klinischen Phase, hat seine Teilnahme an vier bedeutenden Investorenkonferenzen im Gesundheitswesen im November und Dezember 2024 angekündigt. Das Unternehmen wird auf der Guggenheim's Inaugural Healthcare Innovation Conference in Boston, der Jefferies London Healthcare Conference, der Citi's Global Healthcare Conference in Miami und der Evercore ISI HealthCONx Conference in Coral Gables präsentieren. Live-Übertragungen und archivierte Wiederholungen der Präsentationen bei den Konferenzen von Jefferies, Citi und Evercore sind auf der Unternehmenswebsite im Bereich für Investoren und Medien verfügbar.
- None.
- None.
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences:
- Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, 2024, in Boston, MA
- Jefferies London Healthcare Conference on November 19, 2024 presentation at 4:00 p.m. to 4:25 p.m. GDT, in London
- Citi’s 2024 Global Healthcare Conference on December 3, 2024 presentation at 9:30 a.m. to 10:10 a.m. ET, in Miami, FL
- Evercore ISI HealthCONx Conference on December 4, 2024 presentation at 1:20 p.m. to 1:40 p.m. ET, in Coral Gables, FL
Live webcasts and archived replays of the Company’s presentations at the Jefferies, Citi and Evercore conferences can be accessed under “Events and Presentations” in the Investors and Media section of the Zenas BioPharma website.
About Zenas BioPharma, Inc.
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s mechanism of action and chronic dosing regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on X at @ZenasBioPharma and LinkedIn.
The Zenas BioPharma word mark and logos are trademarks of Zenas BioPharma, Inc. or its affiliated companies.
Investor Contact:
Matthew Osborne
Investor Relations and Corporate Communications
Matt.osborne@zenasbio.com
Media Contact:
Argot Partners
Zenas@argotpartners.com
FAQ
When is Zenas BioPharma (ZBIO) presenting at the Jefferies London Healthcare Conference 2024?
Which investor conferences will Zenas BioPharma (ZBIO) attend in November and December 2024?
How can investors access Zenas BioPharma's (ZBIO) conference presentations?
What time is Zenas BioPharma's (ZBIO) presentation at Citi's 2024 Global Healthcare Conference?
